Anne Holck Storås

Anne Holck Storås is an oncologist whose clinical practice and research focuses on urological cancers.

Anne started a 50% postdoc position in the Department of Research in November 2019. Her research uses population-based registry data to evaluate health outcomes among men with metastatic prostate cancer, with a focus on newly approved systemic treatments for advanced disease.



Anne Holck Storås specializes in oncology and received her medical degree (cand. med.) from the University of Oslo.

In 2017, she defended her PhD, titled “Adverse effects after curative treatment for prostate cancer; an international perspective”.

In addition to her position at the Cancer Registry, she also works in a 50% position as an oncologist in the Section for Urological Oncology in the Department of Oncology at the Oslo University Hospital.


Health outcomes and prognostic factors after introduction of new anti-cancer drugs in patients with metastatic prostate cancer: A population-based study

Selected publications

1: Ávila M, Patel L, López S, Cortés-Sanabria L, Garin O, Pont À, Ferrer F, Boladeras A, Zamora V, Fosså S, Storås AH, Sanda M, Serra-Sutton V, Ferrer M.
Patient-reported outcomes after treatment for clinically localized prostate cancer: A systematic review and meta-analysis.
Cancer Treat Rev. 2018 May;66:23-44. doi: 10.1016/j.ctrv.2018.03.005. Epub 2018 Apr 3. Review. PubMed PMID: 29673922.


2: Fosså SD, Storås AH, Steinsvik EA, Myklebust TA, Eri LM, Loge JH, Dahl AA.
Psychometric testing of the Norwegian version of the Expanded Prostate Cancer
Index Composite 26-item version (EPIC-26). Scand J Urol. 2016 Aug;50(4):280-5. doi: 10.3109/21681805.2016.1163617. Epub 2016 Apr 6. PubMed PMID: 27049891.


3: Storås AH, Sanda MG, Boronat OG, Chang P, Patil D, Crociani C, Suarez JF, Cvancarova M, Loge JH, Fosså SD.
Erectile Dysfunction and Sexual Problems Two to Three Years After Prostatectomy Among American, Norwegian, and Spanish Patients.
Clin Genitourin Cancer. 2016 Jun;14(3):e265-73. doi: 10.1016/j.clgc.2015.10.009.

Epub 2015 Oct 26. PubMed PMID: 26778476.


4: Storås AH, Sanda MG, Ferrer M, Loge JH, Dahl AA, Steinsvik EA, Guedea F, Cvancarova M, Fosså SD.
Localized prostate cancer in Norway, the United States, and Spain: between-country differences of variables before treatment among patients eligible for curative treatment.
Clin Genitourin Cancer. 2014 Aug;12(4):e117-25. doi: 10.1016/j.clgc.2013.12.007. Epub 2014 Jan 3. PubMed PMID:24524968; PubMed Central PMCID: PMC5021779.